Colorectal carcinogenesis: Role of oxidative stress and antioxidants

Anticancer Research

Volumn 37, Issue 9, 2017, Pages 4759-4766

  Carini, Francesco ^a,b   Mazzola, Margherita ^a,c   Rappa, Francesca ^a   Jurjus, Abdo ^d,e   Geagea, Alice Gerges ^a,d   Al Kattar, Sahar ^d   Bou Assi, Tarek ^f   Jurjus, Rosalyn ^e   Damiani, Provvidenza ^b   Leone, Angelo ^a   Tomasello, Giovanni ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c Section of Genomics and Personalized Medicine   (Italy)

^d AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

^f Psychiatric Hospital of the Cross   (Lebanon)

Author keywords

Antioxidants; Colorectal cancer; Dysbiosis; Oxidative stress; Review

Indexed keywords

ALPHA TOCOPHEROL; ANTHOCYANIN; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CAROTENOID; CATECHIN; CURCUMIN; DELTA TOCOPHEROL; EPIGALLOCATECHIN GALLATE; FLUOROURACIL; GAMMA TOCOPHEROL; HYDROGEN PEROXIDE; HYDROXYL RADICAL; LYCOPENE; PEROXYNITRITE; POLYPHENOL DERIVATIVE; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; RETINOL; SUPEROXIDE; TOCOPHEROL DERIVATIVE; XANTHOPHYLL; ZEAXANTHIN;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; CANCER STEM CELL; CELL INVASION; CELL POPULATION; CELL PROLIFERATION; COLON CARCINOGENESIS; COLORECTAL CANCER CELL LINE; COLORECTAL CARCINOMA; CURCUMA LONGA; DNA REPAIR; DRUG MECHANISM; HUMAN; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; TEA; ANIMAL; CARCINOGENESIS; COLORECTAL TUMOR; DRUG EFFECTS; METABOLISM; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; CARCINOGENESIS; COLORECTAL NEOPLASMS; HUMANS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 85029438663     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: 10.21873/anticanres.11882     Document Type: Review

References (45)

1. Stone WL, Krishnan K, Campbell SE and Palau VE: The role of antioxidants and pro-oxidants in colon cancer. World J Gastrointest Oncol 6: 55-66, 2014.
2. Rouhollahi E, Moghadamtousi SZ, Al-Henhena N, Kunasegaran T, Hasanpourghadi M, Looi CY, Abd Malek SN, Awang K, Abdulla MA and Mohamed Z: The chemopreventive potential of Curcuma purpurascens rhizome in reducing azoxymethaneinduced aberrant crypt foci in rats. Drug Des Devel Ther 27: 3911-3922, 2015.
3. Link A, Balaguer F, Shen Y, Lozano JJ, Leung HC, Boland CR and Goel A: Curcumin modulates DNA methylation in colorectal cancer cells. PLoS One 8: e57709, 2013.
4. Tomasello G, Tralongo P, Damiani P, Sinagra E, Di Trapani B, Zeenny MN, Hussein H, Jurjus A and Leone A: Dismicrobism in inflammatory bowel disease and colorectal cancer: Changes in response of colocytes. World J Gastroenterol 20: 18121-18130, 2014.
5. Tomasello G, Tralongo P, Jurjus A, MatarM and Angelo L: Targeted therapies for IBD and CRC: An increasing need for microbiotaintestinal mutualism. J Int Transl Med 3: 123-129, 2015.
6. Leone A, Tomasello G, Giammanco M, Di Majo D, Zeenny MN, Damiani P, Jurjus A, Traina G, Sinagra E and Jurjus R: Intestinal microbiota mutualism and gastrointestinal diseases. EMBJ 10: 65-75, 2015.
7. Sinagra E, Tomasello G, Raimondo D, Sturm A, Giunta M, Messina M, Damiano G, Palumbo VD, Rossi F, Facella T, Marasa S, Cottone M and Lo Monte AI: Advanced endoscopic imaging for surveillance for dysplasia and colorectal cancer in inflammatory bowel disease: Could the Pathologist be Further Helped? Saudi J Gastroenterol 20: 26-38, 2014.
8. Cappello F, Conway de Macario E, Marino Gammazza A, Bonaventura G, Carini F, Czarnecka AM, Farina F, Zummo G and Macario AJ: Hsp60 and human aging: Les liaisons dangereuses. Front Biosci 1: 626-637, 2013.
9. Scardina GA, Pisano T, Carini F, Valenza V and Messina P: Burning mouth syndrome: an evaluation of in vivo microcirculation. J Am Dent Assoc 139: 940-946, 2008.
10. Mesa F, O'Valle F, Rizzo M, Cappello F, Donos N, Parkar M, Chaudhary N, Carini F, Munoz R and Nibali L: Association between COX-2 rs 6681231 genotype and interleukin-6 in periodontal connective tissue. A pilot study. PLoS One 9: e87023, 2014.
11. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532, 1988.
12. Tomasello G, Rodolico V, Zerilli M, Martorana A, Bucchieri F, Pitruzzella A, Marino Gammazza A, David S, Rappa F, Zummo G, Damiani P, Accomando S, Rizzo M, de Macario EC, Macario AJ and Cappello F: Changes in immunohistochemical levels and subcellular localization after therapy and correlation and colocalization with CD68 suggest a pathogenetic role of Hsp60 in ulcerative colitis. Appl Immunohistochem Mol Morphol 19: 552-556, 2011.
13. Saud SM, Li W, Morris NL, Matter MS, Colburn NH, Kim YS and Young MR: Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression. Carcinogenesis 35: 2778-2786, 2014.
14. Sreevalsan S and Safe S: Reactive oxygen species and colorectal cancer. Curr Colorectal Cancer Rep 9: 350-357, 2013.
15. Singh SK, Nigam AK, Maraiya D, Singh N and Singh N: Evaluation of oxidative stress and its impact on the antioxidant activities in patients with colorectal carcinoma. Int J Sci Res 4: 337-339, 2015.
16. Pais R and Dumitraşcu DL: Do antioxidants prevent colorectal cancer? A meta-analysis. Rom J Intern Med 51: 152-163, 2013.
17. Slattery ML, Pellatt DF, Mullany LE and Wolff RK: Differential Gene Expression in Colon Tissue Associated With Diet, Lifestyle, and Related Oxidative Stress. PLoS One 10: e0134406, 2015.
18. Goldstein J, Tran B, Ensor J, Gibbs P, Wong HL, Wong SF, Vilar E, Tie J, Broaddus R, Kopetz S, Desai J and Overman MJ: Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H). Ann Oncol 25: 1032-1038, 2014.
19. Mazzola M,Carini F, Leone A, Damiani P, Jurjus A, GergesGeagea A, Jurjus R, Assi TB, Trovato E, Rappa F and Tomasello G: Inflammatory bowel disease and colorectal cancer, nutraceutical aspects. EMBJ 11: 123-129, 2016.
20. Tomasello G, Mazzola M, Leone A, Sinagra E, Zummo G, Farina F, Damiani P, Cappello F, Gerges Geagea A, Jurjus A, Bou Assi T, Messina M and Carini F: Nutrition, oxidative stress and intestinal dysbiosis: Influence of diet on gut microbiota in inflammatory bowel diseases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 160: 461-466, 2016.
21. Bellavia M, Tomasello G, Romeo M, Damiani P, Lo Monte AI, Lozio L, Campanella C, Marino Gammazza A, Rappa F, Zummo G, Cocchi M, Conway de Macario E, Macario AJ and Cappello F: Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis. Med Microbiol Immunol 202: 393-406, 2013.
22. Cardona F, Andres-Lacueva C, Tulipani S, Tinahones FJ and Queipo-Ortuno MI: Benefits of polyphenols on gut microbiota and implications in human health. J NutrBiochem 24: 1415-1422, 2013.
23. Tralongo P, Tomasello G, Sinagra E, Damiani P, Leone A, Palumbo VD, Giammanco M, Di Majo D, Damiani F, Abruzzo A, Bruno A, Cassata G, Cicero L, Noto M, Tomasello R and Lo Monte AI: The role of butyric acid as a protective agent against inflammatory bowel diseases. EMBJ 9: 24-35, 2014.
24. Tomasello G, Bellavia M, Palumbo VD, Gioviale MC, Damiani P and Lo Monte AI. From gut microflora imbalance to mycobacteria infection: is there a relationship with chronic intestinal inflammatory diseases? Ann Ital Chir 82: 361-368, 2011.
25. Espley RV, Butts CA, Laing WA, Martell S, Smith H, McGhie TK, Zhang J, Paturi G, Hedderley D, Bovy A, Schouten HJ, Putterill J, Allan AC and Hellens RP: Dietary flavonoids from modified apple reduce inflammation markers and modulate gut microbiota in mice. J Nutr 144: 146-154, 2014.
26. Yang CS, Li G, Yang Z, Guan F, Chen A and Ju J: Cancer prevention by tocopherols and tea polyphenols. Cancer Lett 334: 79-85, 2013.
27. Oh S, Gwak J, Park S and Yang CS: Green tea polyphenol EGCG suppresses Wnt/β-catenin signaling by promoting GSK-3β-and PP2A-independent β-catenin phosphorylation/degradation. Biofactors 40: 586-595, 2014.
28. Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT and Lee MT: The antitumor activities of flavonoids. In Vivo 19: 895-909, 2005.
29. Nimptsch K, Zhang X, Cassidy A, Song M, O'Reilly EJ, Lin JH, Pischon T, Rimm EB, Willett WC, Fuchs CS, Ogino S, Chan AT, Giovannucci EL and Wu K: Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts. Am J Clin Nutr 103: 184-191, 2016.
30. Pampaloni B, Palmini G, Mavilia C, Zonefrati R, Tanini A and Brandi ML: In vitro effects of polyphenols on colorectal cancer cells. World J Gastrointest Oncol 6: 289-300, 2014.
31. Kim HJ, Kim SK, Kim BS, Lee SH, Park YS, Park BK, Kim SJ, Kim J, Choi C, Kim JS, Cho SD, Jung JW, Roh KH, Kang KS and Jung JY: Apoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway. J Agric Food Chem 58: 8643-8650, 2010.
32. Lim S, Xu J, Kim J, Chen TY, Su X, Standard J, Carey E, Griffin J, Herndon B, Katz B, Tomich J and Wang W: Role of anthocyanin-enriched purple-fleshed sweet potato p40 in colorectal cancer prevention. Mol Nutr Food Res 57: 1908-1917, 2013.
33. Wang LS, Kuo CT, Cho SJ, Seguin C, Siddiqui J, Stoner K, Weng YI, Huang TH, Tichelaar J, Yearsley M, Stoner GD and Huang YW: Black raspberry-derived anthocyanins demethylate tumor suppressor genes through the inhibition of DNMT1 and DNMT3B in colon cancer cells. Nutr Cancer 65: 118-125, 2013.
34. Tramer F, Moze S, Ademosun AO, Passamonti S and Cvorovic j: Dietary anthocyanins: impact on colorectal cancer and mechanisms of action. InTech, 2017. doi: 10.5772/27678. Available from: https://www.intechopen.com/books/colorectalcancer-from-prevention-to-patient-care/dietary-anthocyaninsimpact-on-colorectal-cancer-and-mechanisms-of-action.
35. Shi N, Clinton SK, Liu Z, Wang Y, Riedl KM, Schwartz SJ, Zhang X, Pan Z and Chen T: Strawberry phytochemicals inhibit azoxymethane/dextran sodium sulfate-induced colorectal carcinogenesis in Crj:CD-1 Mice. Nutrients 7: 1696-1715, 2015.
36. Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ and Brown K: Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 70: 7392-7399, 2010.
37. Jiang Q, Jiang Z, Hall YJ, Jang Y, Snyder PW, Bain C, Huang J, Jannasch A, Cooper B, Wang Y and Moreland M: Gammatocopherol attenuates moderate but not severe colitis and suppresses moderate colitis-promoted colon tumorigenesis in mice. Free Radic Biol Med 65: 1069-1077, 2013.
38. Dolfi S, Yang Z, Lee MJ, Guan F, Hong J and Yang C: Inhibitory effects of different forms of tocopherols, tocopherol phosphates and tocopherol quinones on growth of colon cancer cells. J Agric Food Chem 61: 8533-8540, 2013.
39. Milani A, Basirnejad M, Shahbazi S and Bolhassani A: Carotenoids: biochemistry, pharmacology and treatment. Br J Pharmacol 174: 1290-1324, 2017.
40. Mannisto S, Yaun SS, Hunter DJ, Spiegelman D, Adami HO, Albanes D, van den Brandt PA, Buring JE, Cerhan JR, Colditz GA, Freudenheim JL, Fuchs CS, Giovannucci E, Goldbohm RA, Harnack L, Leitzmann M, McCullough ML, Miller AB, Rohan TE, Schatzkin A, Virtamo J, Willett WC, Wolk A, Zhang SM and Smith-Warner SA: Dietary carotenoids and risk of colorectal cancer in a pooled analysis of 11 cohort studies. Am J Epidemiol 165: 246-255, 2007.
41. Pham DN, Leclerc D, Levesque N, Deng L and Rozen R: β,β-Carotene 15,15'-monooxygenase and its substrate b-carotene modulate migration and invasion in colorectal carcinoma cells. Am J Clin Nutr 98: 413-422, 2013.
42. Park SY, Nomura AM, Murphy SP, Wilkens LR, Henderson BE and Kolonel LN: Carotenoid intake and colorectal cancer risk: the multiethnic cohort study. J Epidemiol 19: 63-71, 2009.
43. Chen L, Zhang X, Hao T, Liang R, Bonnie Man S, Huang G and Tang S: Research progress on antioxidant activity of natural products. European Journal of BioMedical Research 2: 36-40, 2016.
44. Kim, Jee Eun, Jae Seung Kang, and Wang Jae Lee: Vitamin C induces apoptosis in human colon cancer cell line, HCT-8 via the modulation of calcium influx in endoplasmic reticulum and the dissociation of bad from 14-3-3β. Immune Netw 12: 189-195, 2012.
45. Yun J, Mullarky E, Lu C, Bosch KN, Kavalier A, Rivera K, Roper J, Chio II, Giannopoulou EG, Rago C, Muley A, Asara JM, Paik J, Elemento O, Chen Z, Pappin DJ, Dow LE, Papadopoulos N, Gross SS and Cantley LC: Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science 350: 1391-1396, 2015.